Organisation
Medical Oncology
Current researchers
1 - 10 of 21 results
- Sandrine Aspeslagh (Member)
- Gil Awada (Member)
- Ruben De Wilde (Member)
- Lore Decoster (Member)
- Iris Dirven (Member)
- Christel Fontaine (Member)
- Mathijs Goossens (Member)
- Mark Gorris (Member)
- Sofie Joris (Member)
- Koen Kortbeek (Member)
Projects
1 - 2 of 2
- Health-related quality of life, psychosocial outcome and neurocognitive function in metastatic cancer survivors treated with immunotherapy, followed by integrative neurocognitive remediation therapyFrom1 Nov 2022 → TodayFunding: FWO fellowships
- A randomized phase II clinical trial in NSCLC combining SBRT and I.V. anti-PD-1 with or without I.T. anti-CTLA-4/anti-PD-L1 plus CD1c+ myDCFrom1 Oct 2019 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
Publications
1 - 10 of 281
- Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors(2016)
Authors: Sandrine Aspeslagh, Ahmad Awada, Arturo S Matos-Pita, Philippe Aftimos, Ratislav Bahleda, Andréa Varga, Jean-Charles Soria
Pages: 1021-1027 - Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease(2018)
Authors: François-Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre, Jean-Marie Michot, Emilie Routier, Laurent Taillade, Stéphane Champiat, Sandrine Aspeslagh, Julien Haroche, Laurence Albiges, et al.
Pages: 21-29 - Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19(2020)
Authors: Evandro de Azambuja, Mariana Brandão, Hans Wildiers, Annouschka Laenen, Sandrine Aspeslagh, Christel Fontaine, Joelle Collignon, Willem Lybaert, Jolanda Verheezen, Annemie Rutten, et al.
- Incidence, evolution and risk factors of hypophosphatemia in patients with solid tumors receiving ferric carboxymaltose(2023)
Authors: Alexander Decruyenaere, Koen Kortbeek, Sigurd Delanghe, Sylvie Rottey, Hannelore Denys, Lore Lapeire
Pages: 298-307 - Immune checkpoint blockade for organ transplant patients with advanced cancer(2019)
Authors: Pauline De Bruyn, Dirk Van Gestel, Piet Ost, Vibeke Kruse, Lieve Brochez, Hans Van Vlierberghe, Arnaud Devresse, Véronique Del Marmol, Alain Le Moine, Sandrine Aspeslagh
Pages: 54-64 - Pneumocystis Infection in Two Patients Treated with Both Immune Checkpoint Inhibitor and Corticoids(2020)
Authors: Maroun Sadek, Angela Loizidou, Annie Drowart, Sigi Van den Wijngaert, Maria Gomez Galdon, Sandrine Aspeslagh
Pages: 27-30 - CHEK2 mutations and papillary thyroid cancer(2022)
Authors: De Putter Robin, Naert Eline, Koen Kortbeek
- Relevance of Geriatric Assessment in Older Patients With Colorectal Cancer(2017)
Authors: Lore Decoster, Leen Vanacker, Cindy Kenis, Hans Prenen, Erik Van Cutsem, Jacques Van Der Auwera, E Van Eetvelde, Katrien Van Puyvelde, Johan Flamaing, Koen Milisen, et al.
Pages: e221-e229 - Choriocapillaris Assessment In Patients Under Mek-Inhibitor Therapy For Cutaneous Melanoma(2021)
Authors: Giuseppe Fasolino, Gil Awada, Jorgos Socrates Koulalis, Bart Neyns, Peter Van Elderen, Robert Kuijpers, Pieter Nelis, Marcel Ten Tusscher
Pages: 765-771 - Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic(2018)
Authors: Jean-François Baurain, Caroline Robert, Laurent Mortier, Bart Neyns, Florent Grange, Céleste Lebbe, Fernando Ulloa-Montoya, Pedro Miguel De Sousa Alves, Marc Gillet, Jamila Louahed, et al.